ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 76 filers reported holding ARCUS BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $202,998 | -63.4% | 9,995 | -62.7% | 0.00% | -100.0% |
| Q4 2022 | $554,307 | -60.2% | 26,804 | -39.2% | 0.00% | 0.0% |
| Q1 2022 | $1,391,000 | -89.7% | 44,087 | -86.8% | 0.00% | -90.9% |
| Q4 2021 | $13,477,000 | +100.3% | 332,994 | +72.6% | 0.01% | +83.3% |
| Q3 2021 | $6,729,000 | -31.0% | 192,963 | -45.6% | 0.01% | -25.0% |
| Q2 2021 | $9,746,000 | -37.9% | 354,946 | -36.5% | 0.01% | -46.7% |
| Q1 2021 | $15,706,000 | +6.3% | 559,309 | -1.8% | 0.02% | +15.4% |
| Q4 2020 | $14,780,000 | +40.4% | 569,333 | -7.3% | 0.01% | +18.2% |
| Q3 2020 | $10,525,000 | -4.5% | 614,037 | +37.9% | 0.01% | -15.4% |
| Q2 2020 | $11,016,000 | +3198.2% | 445,282 | +1245.3% | 0.01% | – |
| Q4 2019 | $334,000 | – | 33,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $65,241,000 | 19.83% |
| Octagon Capital Advisors LP | 2,095,231 | $84,794,000 | 16.50% |
| EcoR1 Capital, LLC | 5,523,358 | $223,530,000 | 7.12% |
| BVF INC/IL | 3,398,067 | $137,520,000 | 4.99% |
| PFM Health Sciences, LP | 3,431,010 | $138,853,000 | 4.73% |
| Alphabet Inc. | 2,563,441 | $103,742,000 | 2.50% |
| Boxer Capital, LLC | 1,432,200 | $57,961,000 | 2.25% |
| PARK CIRCLE Co | 64,000 | $2,590,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 283,210 | $11,462,000 | 1.72% |
| DAFNA Capital Management LLC | 117,200 | $4,743,000 | 1.19% |